Lapatinib Completed Phase 1 Trials for Metastatic Breast Cancer (MBC) / Locally Advanced Breast Cancer (LABC) Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT01471847A Phase Ib/II Study of BEZ235 and Trastuzumab in Patients With HER2-positive Breast Cancer Who Failed Prior to Trastuzumab